Daniels Mark 4
4 · Twist Bioscience Corp · Filed Mar 31, 2021
Insider Transaction Report
Form 4
Daniels Mark
Chief Compliance Officer & GC
Transactions
- Sale
Common Stock
2021-03-29$114.39/sh−377$43,125→ 66,926 total - Exercise/Conversion
Common Stock
2021-03-29$8.82/sh+377$3,325→ 67,303 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-03-29−377→ 2,261 totalExercise: $8.82Exp: 2027-09-28→ Common Stock (377 underlying)
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020.
- [F2]The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.